Durham, NC
Website: Duke Cancer Institute
Durham, NC
Website: Duke Cancer Institute
Phase I/II Study of Stereotactic Radiosurgery with Concurrent Administration of Olaparib Followed by Adjuvant Combination of Durvalumab and Physician’s Choice Systemic Therapy in Subjects with Breast Cancer Brain Metastases
Status: Open to Accrual
BRIDGET: Secondary BRain metastases prevention after Isolated intracranial progression on Trastuzumab/Pertuzumab or T-DM1 in patients with aDvanced human epidermal Growth factor receptor 2+ brEast cancer with the addition of Tucatinib
Status: Open to Accrual
A Phase II Study of GT103 in Combination with Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer
Status: Open to Accrual
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter